Inventor
JACQUES VINCENT
US31 patents
⚠️ This page may combine multiple inventors who share the name “JACQUES VINCENT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOMARIN PHARM INC
9 patentsUS9512143B2Dec 6, 2016
Histone deacetylase inhibitors
BIOMARIN PHARM INC11 citations92
US9908899B2Mar 6, 2018
Histone deacetylase inhibitors
BIOMARIN PHARM INC5 citations84
US10981933B2Apr 20, 2021
Histone deacetylase inhibitors
BIOMARIN PHARM INC0 citations62
US10526346B2Jan 7, 2020
Histone deacetylase inhibitors
BIOMARIN PHARM INC0 citations52
US10301323B2May 28, 2019
Histone deacetylase inhibitors
BIOMARIN PHARM INC0 citations52
US10280182B2May 7, 2019
Histone deacetylase inhibitors
BIOMARIN PHARM INC0 citations52
US10059723B2Aug 28, 2018
Histone deacetylase inhibitors
BIOMARIN PHARM INC1 citations52
US10428028B2Oct 1, 2019
HDAC inhibitors
BIOMARIN PHARM INC0 citations51
US10029988B2Jul 24, 2018
HDAC inhibitors
BIOMARIN PHARM INC1 citations51
POXEL SA
6 patentsUS11123336B2Sep 21, 2021
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
POXEL SA2 citations71
US10265305B2Apr 23, 2019
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
POXEL SA2 citations71
US11918569B2Mar 5, 2024
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
POXEL SA0 citations60
US11141411B2Oct 12, 2021
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
POXEL SA0 citations60
US11319313B2May 3, 2022
Crystalline forms of deuterium-enriched pioglitazone
POXEL SA0 citations54
US11767317B1Sep 26, 2023
Methods of synthesizing enantiopure deuterium-enriched pioglitazone
POXEL SA0 citations44
DEUTERX LLC
5 patentsUS9732031B2Aug 15, 2017
Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
DEUTERX LLC121 citations97
US9809603B1Nov 7, 2017
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
DEUTERX LLC12 citations83
US10188639B2Jan 29, 2019
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
DEUTERX LLC3 citations72
US10189858B2Jan 29, 2019
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
DEUTERX LLC3 citations72
US12180137B1Dec 31, 2024
Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereof
DEUTERX LLC0 citations52